231 related articles for article (PubMed ID: 31793743)
1. Endothelial MT1-MMP targeting limits intussusceptive angiogenesis and colitis via TSP1/nitric oxide axis.
Esteban S; Clemente C; Koziol A; Gonzalo P; Rius C; Martínez F; Linares PM; Chaparro M; Urzainqui A; Andrés V; Seiki M; Gisbert JP; Arroyo AG
EMBO Mol Med; 2020 Feb; 12(2):e10862. PubMed ID: 31793743
[TBL] [Abstract][Full Text] [Related]
2. "Splitting the matrix": intussusceptive angiogenesis meets MT1-MMP.
D'Amico G; Muñoz-Félix JM; Pedrosa AR; Hodivala-Dilke KM
EMBO Mol Med; 2020 Feb; 12(2):e11663. PubMed ID: 31858727
[TBL] [Abstract][Full Text] [Related]
3. Functional interplay between endothelial nitric oxide synthase and membrane type 1 matrix metalloproteinase in migrating endothelial cells.
Genís L; Gonzalo P; Tutor AS; Gálvez BG; Martínez-Ruiz A; Zaragoza C; Lamas S; Tryggvason K; Apte SS; Arroyo AG
Blood; 2007 Oct; 110(8):2916-23. PubMed ID: 17606763
[TBL] [Abstract][Full Text] [Related]
4. Membrane type 1-matrix metalloproteinase is regulated by chemokines monocyte-chemoattractant protein-1/ccl2 and interleukin-8/CXCL8 in endothelial cells during angiogenesis.
Gálvez BG; Genís L; Matías-Román S; Oblander SA; Tryggvason K; Apte SS; Arroyo AG
J Biol Chem; 2005 Jan; 280(2):1292-8. PubMed ID: 15516694
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-induced intussusceptive angiogenesis in murine colitis.
Konerding MA; Turhan A; Ravnic DJ; Lin M; Fuchs C; Secomb TW; Tsuda A; Mentzer SJ
Anat Rec (Hoboken); 2010 May; 293(5):849-57. PubMed ID: 20225210
[TBL] [Abstract][Full Text] [Related]
6. The protease MT1-MMP drives a combinatorial proteolytic program in activated endothelial cells.
Koziol A; Gonzalo P; Mota A; Pollán Á; Lorenzo C; Colomé N; Montaner D; Dopazo J; Arribas J; Canals F; Arroyo AG
FASEB J; 2012 Nov; 26(11):4481-94. PubMed ID: 22859368
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-1 inhibits nitric oxide signaling via CD36 by inhibiting myristic acid uptake.
Isenberg JS; Jia Y; Fukuyama J; Switzer CH; Wink DA; Roberts DD
J Biol Chem; 2007 May; 282(21):15404-15. PubMed ID: 17416590
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease.
Arroyo AG; Genís L; Gonzalo P; Matías-Román S; Pollán A; Gálvez BG
Curr Pharm Des; 2007; 13(17):1787-802. PubMed ID: 17584108
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between neovessels and mural cells directs the site-specific expression of MT1-MMP to endothelial tip cells.
Yana I; Sagara H; Takaki S; Takatsu K; Nakamura K; Nakao K; Katsuki M; Taniguchi S; Aoki T; Sato H; Weiss SJ; Seiki M
J Cell Sci; 2007 May; 120(Pt 9):1607-14. PubMed ID: 17405818
[TBL] [Abstract][Full Text] [Related]
11. The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells.
Barillari G; Iovane A; Bacigalupo I; Labbaye C; Chiozzini C; Sernicola L; Quaranta MT; Falchi M; Sgadari C; Ensoli B
Angiogenesis; 2014 Oct; 17(4):831-8. PubMed ID: 24719186
[TBL] [Abstract][Full Text] [Related]
12. MT1-MMP: universal or particular player in angiogenesis?
Genís L; Gálvez BG; Gonzalo P; Arroyo AG
Cancer Metastasis Rev; 2006 Mar; 25(1):77-86. PubMed ID: 16680574
[TBL] [Abstract][Full Text] [Related]
13. Expression of thrombospondin-1 modulates the angioinflammatory phenotype of choroidal endothelial cells.
Fei P; Zaitoun I; Farnoodian M; Fisk DL; Wang S; Sorenson CM; Sheibani N
PLoS One; 2014; 9(12):e116423. PubMed ID: 25548916
[TBL] [Abstract][Full Text] [Related]
14. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts.
Isenberg JS; Pappan LK; Romeo MJ; Abu-Asab M; Tsokos M; Wink DA; Frazier WA; Roberts DD
Ann Surg; 2008 Jan; 247(1):180-90. PubMed ID: 18156939
[TBL] [Abstract][Full Text] [Related]
15. Elastokine-mediated up-regulation of MT1-MMP is triggered by nitric oxide in endothelial cells.
Fahem A; Robinet A; Cauchard JH; Duca L; Soula-Rothhut M; Rothhut B; Soria C; Guenounou M; Hornebeck W; Bellon G
Int J Biochem Cell Biol; 2008; 40(8):1581-96. PubMed ID: 18206415
[TBL] [Abstract][Full Text] [Related]
16. TSP1 ameliorates age-related macular degeneration by regulating the STAT3-iNOS signaling pathway.
Li J; He J; Zhang X; Li J; Zhao P; Fei P
Exp Cell Res; 2020 Mar; 388(1):111811. PubMed ID: 31899207
[TBL] [Abstract][Full Text] [Related]
17. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
Isenberg JS; Hyodo F; Pappan LK; Abu-Asab M; Tsokos M; Krishna MC; Frazier WA; Roberts DD
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2582-8. PubMed ID: 17916772
[TBL] [Abstract][Full Text] [Related]
18. The type I collagen induction of MT1-MMP-mediated MMP-2 activation is repressed by alphaVbeta3 integrin in human breast cancer cells.
Borrirukwanit K; Lafleur MA; Mercuri FA; Blick T; Price JT; Fridman R; Pereira JJ; Leardkamonkarn V; Thompson EW
Matrix Biol; 2007 May; 26(4):291-305. PubMed ID: 17175151
[TBL] [Abstract][Full Text] [Related]
19. Targeting the MMP-14/MMP-2/integrin α
Yosef G; Arkadash V; Papo N
J Biol Chem; 2018 Aug; 293(34):13310-13326. PubMed ID: 29986882
[TBL] [Abstract][Full Text] [Related]
20. Less is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.
Cepeda MA; Pelling JJ; Evered CL; Williams KC; Freedman Z; Stan I; Willson JA; Leong HS; Damjanovski S
Mol Cancer; 2016 Oct; 15(1):65. PubMed ID: 27756325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
